Integer Holdings Co. (NYSE:ITGR) Position Raised by Tributary Capital Management LLC

Tributary Capital Management LLC raised its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 1.2% during the 1st quarter, Holdings Channel.com reports. The firm owned 285,677 shares of the medical equipment provider’s stock after acquiring an additional 3,513 shares during the quarter. Integer comprises approximately 2.7% of Tributary Capital Management LLC’s holdings, making the stock its biggest position. Tributary Capital Management LLC’s holdings in Integer were worth $33,333,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ITGR. Blue Trust Inc. lifted its holdings in shares of Integer by 483.3% in the fourth quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock worth $45,000 after buying an additional 377 shares in the last quarter. Principal Securities Inc. purchased a new stake in shares of Integer in the fourth quarter worth about $67,000. Quadrant Capital Group LLC lifted its holdings in shares of Integer by 10.2% in the fourth quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock worth $141,000 after buying an additional 132 shares in the last quarter. Strs Ohio lifted its holdings in shares of Integer by 54.5% in the fourth quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock worth $168,000 after buying an additional 600 shares in the last quarter. Finally, Acadian Asset Management LLC bought a new position in shares of Integer in the third quarter worth approximately $182,000. 99.29% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director James F. Hinrichs sold 9,603 shares of the stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $122.44, for a total transaction of $1,175,791.32. Following the completion of the sale, the director now owns 7,424 shares of the company’s stock, valued at $908,994.56. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, Director James F. Hinrichs sold 9,603 shares of the stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $122.44, for a total transaction of $1,175,791.32. Following the completion of the sale, the director now owns 7,424 shares of the company’s stock, valued at $908,994.56. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Andrew Senn sold 5,000 shares of the stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $113.14, for a total value of $565,700.00. Following the sale, the senior vice president now directly owns 4,658 shares of the company’s stock, valued at approximately $527,006.12. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,936 shares of company stock valued at $2,130,937. 2.00% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ITGR has been the topic of several research analyst reports. Bank of America upgraded shares of Integer from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $105.00 to $135.00 in a research report on Monday, April 15th. Citigroup upped their price objective on shares of Integer from $118.00 to $124.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 22nd. Truist Financial initiated coverage on shares of Integer in a research report on Wednesday, May 15th. They issued a “buy” rating and a $137.00 price objective on the stock. Benchmark restated a “buy” rating and issued a $130.00 price objective on shares of Integer in a research report on Friday, May 10th. Finally, CL King initiated coverage on shares of Integer in a research report on Thursday, March 14th. They issued a “buy” rating and a $137.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Integer has a consensus rating of “Moderate Buy” and an average price target of $128.00.

Integer Price Performance

NYSE ITGR traded down $0.63 on Monday, reaching $115.16. 183,849 shares of the company’s stock traded hands, compared to its average volume of 323,198. Integer Holdings Co. has a 12 month low of $69.40 and a 12 month high of $123.99. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.32 and a quick ratio of 2.01. The stock has a 50-day simple moving average of $116.86 and a 200 day simple moving average of $110.56. The stock has a market cap of $3.86 billion, a PE ratio of 39.85, a P/E/G ratio of 1.71 and a beta of 1.11.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 EPS for the quarter, beating analysts’ consensus estimates of $1.12 by $0.02. Integer had a net margin of 6.01% and a return on equity of 11.25%. The business had revenue of $414.80 million for the quarter, compared to analysts’ expectations of $412.78 million. During the same period last year, the business earned $0.87 earnings per share. The business’s quarterly revenue was up 9.5% on a year-over-year basis. As a group, research analysts predict that Integer Holdings Co. will post 5.27 earnings per share for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.